Drug Information

Drug (ID: DG01076) and It's Reported Resistant Information

• Name: Unithiol
• Synonyms: Unithiol; 4076-02-2; Sodium 2,3-dimercapto-1-propanesulfonate; DMPS; Sodium 2,3-dimercaptopropane-1-sulfonate; UNITIOL; Dimaval; 1-Propanesulfonic acid, 2,3-dimercapto-, monosodium salt; sodium 2,3-dimercaptopropanesulfonate; sodium;2,3-bis(sulfanyl)propane-1-sulfonate; 2,3-Dimercapto-1-propanesulfonic acid sodium salt; sodium 2,3-disulfanylpropane-1-sulfonate; Sodium 2,3-dimercaptopropanesulphonate; Unithiolum; Sodium 2,3-dithiolpropanesulfonate; EINECS 223-796-3; 2,3-Dimercaptopropane sodium sulphonate; (+)-Dmps; (-)-Dmps; sodium 2,3-bis(sulfanyl)propane-1-sulfonate; C3H7O3S3Na; 2,3-Dimercaptopropanesulfonic acid sodium salt; C3H7NaO3S3.H2O; SCHEMBL164318; NIOSH/TZ6420050; NIOSH/TZ6420100; DTXSID40958410; AMY22488; MFCD00007523; STL372655; AKOS015898653; AKOS015967317; AS-64437; P323; 2,3-DIMERCAPTOPROPANESULFONIC SODIUM; DB-049647; FT-0609675; TZ64200500; TZ64201000; H10946; A923350; (+)-2,3-Dimercapto-1-propanesulfonate sodium salt; (-)-2,3-Dimercapto-1-propanesulfonate sodium salt; d-2,3-Dimercapto-1-propanesulfonic acid sodium salt; l-2,3-Dimercapto-1-propanesulfonic acid sodium salt; Q-201912; Q26841293; 207233-91-8 (. H2O); 1-Propanesulfonic acid, 2,3-dimercapto-, sodium salt, (+)-; 1-Propanesulfonic acid, 2,3-dimercapto-, sodium salt, (-)-; 37260-06-3
• Indication:
  In total 1 Indication(s)
  Metal intoxication [ICD-11: NE60]; Approved; [1]
• Target: .; NOUNIPROTAC; [1]
• Formula: C3H7NaO3S3
• IsoSMILES: C(C(CS(=O)(=O)[O-])S)S.[Na+]
• InChI: 1S/C3H8O3S3.Na/c4-9(5,6)2-3(8)1-7;/h3,7-8H,1-2H2,(H,4,5,6);/q;+1/p-1
• InChIKey: FGGPAWQCCGEWTJ-UHFFFAOYSA-M
• PubChem CID: 2724039
• TTD Drug ID: D06UNR

Type(s) of Resistant Mechanism of This Drug

  ADTT: Aberration of the Drug's Therapeutic Target

  DISM: Drug Inactivation by Structure Modification

Drug Resistance Data Categorized by Their Corresponding Diseases

ICD-01: Infectious/parasitic diseases

Pseudomonas aeruginosa infection [ICD-11: 1A0Y]

Drug Sensitivity Data Categorized by Their Corresponding Mechanisms

Aberration of the Drug's Therapeutic Target (ADTT)

Key Molecule: Vimentin 2, pseudogene (VIM2P) [1]

• Molecule Alteration: Function; Inhibition
• Sensitive Disease: Pseudomonas aeruginosa infection [ICD-11: 1A00-1C4Z]
• Experimental Note: Discovered Using In-vivo Testing Model
• In Vitro Model: Schistosoma mansoni isolates; 6183
• In Vitro Model: SH-1-V1 cells; Esophagus; Homo sapiens (Human); N.A.
• Experiment for Molecule Alteration: Molecular modeling assay
• Experiment for Drug Resistance: Double-disk diffusion test assay
• Mechanism Description: Disk diffusion and broth microdilution methods demonstrate that unithiol inhibits native MBLs NDM-1 and VIM-2 produced by carbapenem-resistant K. pneumoniae and P. aeruginosa bacterial strains.

ICD-12: Respiratory system diseases

Pneumonia [ICD-11: CA40]

Drug Sensitivity Data Categorized by Their Corresponding Mechanisms

Drug Inactivation by Structure Modification (DISM)

Key Molecule: Metallo-beta-lactamase type 2 (BLAN1) [1]

• Molecule Alteration: Function; Inhibition
• Sensitive Disease: Klebsiella pneumoniae infection [ICD-11: CA40.1]
• Experimental Note: Discovered Using In-vivo Testing Model
• In Vitro Model: Klebsiella pneumoniae strain 409; 573
• In Vitro Model: Klebsiella pneumoniae strain 410; 573
• Experiment for Molecule Alteration: Molecular modeling assay
• Experiment for Drug Resistance: Double-disk diffusion test assay
• Mechanism Description: Disk diffusion and broth microdilution methods demonstrate that unithiol inhibits native MBLs NDM-1 and VIM-2 produced by carbapenem-resistant K. pneumoniae and P. aeruginosa bacterial strains.

References

• Ref 1: Drug Repurposing of the Unithiol: Inhibition of Metallo-Beta-Lactamases for the Treatment of Carbapenem-Resistant Gram-Negative Bacterial Infections .Int J Mol Sci. 2022 Feb 6;23(3):1834. doi: 10.3390/ijms23031834. 10.3390/ijms23031834